Priority 9 from the Sight Loss and Vision PSP Age Related Macular Degeneration
UNCERTAINTY: Can dietary factors, nutritional supplements, complementary therapies or lifestyle changes prevent or slow the progression of AMD? (JLA PSP Priority 9)
|JLA question ID
|Reliable up-to-date systematic reviews revealed important continuing uncertainties about treatment effects at the time of the PSP
Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD000253. DOI: 10.1002/14651858.CD000253.pub3.
Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD000254. DOI: 10.1002/14651858.CD000254.pub3
Lawrenson JG, Evans JR. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010015. DOI: 10.1002/14651858.CD010015.pub2
Evans JR. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD001775. DOI: 10.1002/14651858.CD001775.pub2.
|Health Research Classification System category
|Extra information provided by this PSP
|Original uncertainty examples
|This is an indicative uncertainty and was submitted twice, and the following submissions were merged to form this uncertainty: Which supplements can improve macular health?
|Systematic reviews that need updating or extending
|Systematic reviews in preparation (at time of PSP)
|Ongoing controlled trials
Intervention trial in early age-related macular degeneration I-TEAM NCT01694680
Walnuts and Healthy Aging WAHA NCT01634841
Effect of saffron supplementation on macular cone-mediated function in Age-related macular degeneration safAMD NCT00951288
|Outcomes to be measured
|Change in symptoms; adverse effects or complications; acceptability to the patient; and cost
|PSP unique ID
|Sight Loss and Vision - Age Related Macular Degeneration
|Total number of uncertainties identified by this PSP.
|113 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|April and May 2013